Jpmorgan Chase & CO Alector, Inc. Transaction History

Jpmorgan Chase & CO

  • $1.23 Trillion
  • Q4 2024

A detailed history of Jpmorgan Chase & CO transactions in Alector, Inc. stock. As of the latest transaction made, Jpmorgan Chase & CO holds 1,642,570 shares of ALEC stock, worth $3.01 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,642,570
Previous 2,728,823 39.81%
Holding current value
$3.01 Million
Previous $12.7 Million 75.64%
% of portfolio
0.0%
Previous 0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 12, 2025
SELL
$1.72 - $6.06 $1.87 Million - $6.58 Million
-1,086,253 Reduced 39.81%
1,642,570 $3.1 Million
Q3 2024

Dec 26, 2024
BUY
$4.34 - $6.58 $4.65 Million - $7.06 Million
1,072,298 Added 64.73%
2,728,823 $12.7 Million
Q3 2024

Nov 08, 2024
BUY
$4.34 - $6.58 $4.65 Million - $7.06 Million
1,072,298 Added 64.73%
2,728,823 $12.7 Million
Q2 2024

Dec 26, 2024
SELL
$4.19 - $6.23 $4.49 Million - $6.68 Million
-1,072,298 Reduced 39.3%
1,656,525 $7.52 Million
Q2 2024

Aug 12, 2024
SELL
$4.19 - $6.23 $248,211 - $369,058
-59,239 Reduced 3.45%
1,656,525 $7.52 Million
Q1 2024

Dec 26, 2024
SELL
$5.69 - $8.08 $5.76 Million - $8.19 Million
-1,013,059 Reduced 37.12%
1,715,764 $10.3 Million
Q1 2024

May 10, 2024
SELL
$5.69 - $8.08 $843,451 - $1.2 Million
-148,234 Reduced 7.95%
1,715,764 $10.3 Million
Q4 2023

Dec 26, 2024
SELL
$3.77 - $8.39 $3.26 Million - $7.26 Million
-864,825 Reduced 31.69%
1,863,998 $14.9 Million
Q4 2023

Feb 12, 2024
SELL
$3.77 - $8.39 $1.6 Million - $3.56 Million
-424,371 Reduced 18.54%
1,863,998 $14.9 Million
Q3 2023

Nov 14, 2023
SELL
$5.2 - $8.77 $549,614 - $926,945
-105,695 Reduced 4.41%
2,288,369 $14.8 Million
Q2 2023

Aug 11, 2023
BUY
$5.86 - $7.93 $70,800 - $95,810
12,082 Added 0.51%
2,394,064 $14.4 Million
Q1 2023

May 18, 2023
BUY
$5.85 - $9.84 $454,036 - $763,711
77,613 Added 3.37%
2,381,982 $14.7 Million
Q1 2023

May 11, 2023
SELL
$5.85 - $9.84 $678,161 - $1.14 Million
-115,925 Reduced 4.79%
2,304,369 $14.3 Million
Q4 2022

Feb 13, 2023
BUY
$6.88 - $9.55 $249,076 - $345,738
36,203 Added 1.52%
2,420,294 $22.3 Million
Q3 2022

Nov 14, 2022
SELL
$8.19 - $13.2 $743,635 - $1.2 Million
-90,798 Reduced 3.67%
2,384,091 $22.6 Million
Q2 2022

Aug 11, 2022
BUY
$7.65 - $14.24 $147,813 - $275,145
19,322 Added 0.79%
2,474,889 $25.1 Million
Q1 2022

May 11, 2022
SELL
$13.02 - $20.78 $925,305 - $1.48 Million
-71,068 Reduced 2.81%
2,455,567 $35 Million
Q4 2021

Feb 10, 2022
SELL
$19.35 - $25.54 $643,542 - $849,409
-33,258 Reduced 1.3%
2,526,635 $52.2 Million
Q3 2021

Nov 12, 2021
BUY
$21.65 - $39.49 $55.4 Million - $101 Million
2,559,893 New
2,559,893 $58.4 Million

Others Institutions Holding ALEC

# of Institutions
155
Shares Held
55M
Call Options Held
39.7K
Put Options Held
51K
View Full List

About Alector, Inc.

ALEC Quotes by TradingView
  • Ticker ALEC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 82,563,904
  • Market Cap $151M
  • Description
  • Alector, Inc., a clinical stage biopharmaceutical company, develops therapies for the treatment of neurodegeneration diseases. Its products include AL001, a humanized recombinant monoclonal antibody, which is in Phase III clinical trial for the treatment of frontotemporal dementia, Alzheimer's, Parkinson's, and amyotrophic lateral sclerosis dise...
More about ALEC
Track This Portfolio

Track Jpmorgan Chase & CO Portfolio

Follow Jpmorgan Chase & CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email